PetMed Express Inc. (PETS) CEO Menderes Akdag Sells 10,000 Shares
PetMed Express Inc. (NASDAQ:PETS) CEO Menderes Akdag sold 10,000 shares of the business’s stock in a transaction on Monday, October 10th. The stock was sold at an average price of $21.00, for a total transaction of $210,000.00. Following the transaction, the chief executive officer now directly owns 600,000 shares in the company, valued at $12,600,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Menderes Akdag also recently made the following trade(s):
- On Thursday, September 22nd, Menderes Akdag sold 10,000 shares of PetMed Express stock. The stock was sold at an average price of $20.75, for a total transaction of $207,500.00.
Shares of PetMed Express Inc. (NASDAQ:PETS) opened at 20.32 on Wednesday. PetMed Express Inc. has a 1-year low of $15.61 and a 1-year high of $21.16. The firm’s 50-day moving average is $20.41 and its 200 day moving average is $19.28. The company has a market cap of $410.06 million, a price-to-earnings ratio of 19.35 and a beta of 1.07.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/12/petmed-express-inc-pets-ceo-menderes-akdag-sells-10000-shares.html
PetMed Express (NASDAQ:PETS) last released its quarterly earnings data on Monday, July 25th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.01. PetMed Express had a return on equity of 25.97% and a net margin of 9.09%. The firm had revenue of $72.50 million for the quarter. During the same quarter in the prior year, the company posted $0.29 EPS. The company’s quarterly revenue was up 1.3% on a year-over-year basis. Equities analysts expect that PetMed Express Inc. will post $1.11 EPS for the current fiscal year.
Institutional investors have recently added to or reduced their stakes in the company. NEXT Financial Group Inc increased its position in PetMed Express by 167.2% in the second quarter. NEXT Financial Group Inc now owns 5,354 shares of the company’s stock worth $100,000 after buying an additional 3,350 shares in the last quarter. BNP Paribas Arbitrage SA increased its position in PetMed Express by 101.2% in the second quarter. BNP Paribas Arbitrage SA now owns 6,206 shares of the company’s stock worth $116,000 after buying an additional 3,121 shares in the last quarter. Royal Bank of Canada increased its position in PetMed Express by 19.6% in the second quarter. Royal Bank of Canada now owns 6,423 shares of the company’s stock worth $120,000 after buying an additional 1,053 shares in the last quarter. Cutler Group LP increased its position in PetMed Express by 832.0% in the second quarter. Cutler Group LP now owns 7,064 shares of the company’s stock worth $132,000 after buying an additional 8,029 shares in the last quarter. Finally, Bank of Montreal Can purchased a new position in PetMed Express during the second quarter worth approximately $143,000. Hedge funds and other institutional investors own 75.97% of the company’s stock.
PETS has been the subject of a number of research analyst reports. Zacks Investment Research upgraded shares of PetMed Express from a “hold” rating to a “buy” rating and set a $23.00 price target for the company in a research note on Wednesday, July 27th. Credit Suisse Group AG restated a “sell” rating and issued a $13.00 price target on shares of PetMed Express in a research note on Tuesday, August 16th.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.